Adherence challenges and opportunities for optimizing care through enhanced adherence counseling for adolescents with suspected HIV treatment failure in Kenya

Michelle M Gill, James N Ndimbii, Rose Otieno-Masaba, Millicent Ouma, Stella Jabuto, Boniface Ochanda, Michelle M Gill, James N Ndimbii, Rose Otieno-Masaba, Millicent Ouma, Stella Jabuto, Boniface Ochanda

Abstract

Background: Adolescents living with HIV (ALHIV) experience higher mortality and are more likely to have poor antiretroviral therapy (ART) adherence and unsuppressed viral load (VL) compared to adults. Enhanced adherence counseling (EAC) is a client-centered counseling strategy that aims to identify and address barriers to optimal ART use and can be tailored to the unique needs of adolescents. This study aimed to better understand adherence barriers among ALHIV with suspected treatment failure and their experience with EAC to inform future programming.

Methods: A qualitative study was conducted in Homa Bay and Turkana counties, Kenya in 2019 with adolescents and caregivers of children and adolescents living with HIV with suspected treatment failure after ≥6 months on ART and who had received ≥1 EAC sessions. Sixteen focus group discussions (FGDs) were conducted; five FGDs each were held with adolescents 12-14 years (n = 48) and 15-19 years (n = 36). Caregivers (n = 52) participated in six FGDs. Additionally, 17 healthcare workers providing pediatric/adolescent HIV services participated in in-depth interviews. Audio recordings were transcribed and translated from Kiswahili or Dholuo into English and coded using MAXQDA software. Data were thematically analyzed by participant group.

Results: Participants identified adolescents' fear of being stigmatized due to their HIV status and their relationship with and level of support provided by caregivers. This underpinned and often undermined adolescents' ART-taking behavior and progress towards more independent medication management. Adolescents were generally satisfied with EAC and perceived it to be important in improving adherence and reducing VL. However, problems were noted with facility-based, individual EAC counseling, including judgmental attitudes of providers and difficulties traveling to and keeping EAC clinic appointments. Participant-suggested improvements to EAC included peer support groups in addition to individual counseling, allowing for greater flexibility in the timing and location of sessions and greater caregiver involvement.

Conclusions: The findings provide opportunities to better tailor EAC interventions to promote improved ALHIV adherence and caregiver-supported disease management. Multi-prong EAC interventions that include peer-led and community approaches and target adolescent and caregiver treatment literacy may improve EAC delivery, address issues contributing to poor adherence, and position adolescents to achieve viral suppression.

Trial registration: ClinicalTrials.gov : NCT04915469.

Keywords: Adherence; Adolescents; Children; Counseling; HIV; Kenya; Viral load.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

References

    1. UNICEF: Paediatric care and treatment. (2021). Accessed 20 July 2021.
    1. UNICEF: Adolescent HIV prevention. (2021). Accessed 20 July 2021.
    1. AIDSinfo. UNAIDS, Geneva, Switzerland. 2020. . Accessed 20 July 2021.
    1. Institute for Health Metrics and Evaluation: Kenya. (2019). Accessed 20 July 2021.
    1. National AIDS Control Council (NACC): Kenya AIDS Strategic Framework II: Sustain Gains, Bridge Gaps and Accelerate Progress. (2020). Accessed 2 June 2021.
    1. Kranzer K, Bradley J, Musaazi J, Nyathi M, Gunguwo H, Ndebele W, et al. Loss to follow-up among children and adolescents growing up with HIV infection: age really matters. J Int AIDS Soc. 2017. 10.7448/IAS.20.1.21737.
    1. Lamb MR, Fayorsey R, Nuwagaba-Biribonwoha H, Viola V, Mutabazi V, Alwar T, et al. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care. AIDS. 2014. 10.1097/QAD.0000000000000054.
    1. Koech E, Teasdale CA, Wang C, Fayorsey R, Alwar T, Mukui IN, et al. Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya. AIDS. 2014. 10.1097/QAD.0000000000000473.
    1. Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, et al. Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004–2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1097–1103.
    1. Jiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, et al. HIV viral load suppression in adults and children receiving antiretroviral therapy: results from the IeDEA collaboration. J Acquir Immune Defic Syndr. 2017. 10.1097/QAI.0000000000001499.
    1. Kenya Ministry of Health, National AIDS and STI Control Programme (NASCOP): Preliminary KENPHIA 2018 Report. (2020). Accessed 10 May 2021.
    1. Mwau M, Syeunda CA, Adhiambo M, Bwana P, Kithinji L, Mwende J, et al. Scale-up of Kenya’s national HIV viral load program: findings and lessons learned. PLoS One. 2018. 10.1371/journal.pone.0190659.
    1. Kenya Ministry of Health, NASCOP: Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya. (2018). Accessed 23 December 2021.
    1. Kenya Ministry of Health, NASCOP: Adolescent’s package of Care in Kenya: a healthcare provider guide to adolescent care. 2014. . Accessed 24 Feb 2022.
    1. Ford N, Orrell C, Shubber Z, Tsitsi A, Vojnov L. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019. 10.1002/jia2.25415.
    1. Lejone TI, Ringera I, Cheleboi M, Wagner S, Muhairwe J, Klimkait T, et al. The treatment cascade in children with unsuppressed viral load: a reality check in rural Lesotho, southern Africa. J Acquir Immune Defic Syndr. 2018;77:250–256. doi: 10.1097/QAI.0000000000001597.
    1. Nasuuna E, Kigozi J, Babirye L, Muganzi A, Sewankambo NK, Nakanjako D. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018. 10.1186/s12889-018-5964-x.
    1. Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors associated with virological failure and suppression after enhanced adherence counseling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015. 10.1371/journal.pone.0116144.
    1. Denison JA, Packer C, Stalter RM, Banda H, Mercer S, Nyambe N, et al. Factors related to incomplete adherence to antiretroviral therapy among adolescents attending three HIV clinics in the Copperbelt. Zambia AIDS Behav. 2018. 10.1007/s10461-017-1944-x.
    1. Lanyon C, Seeley J, Namukwaya S, Musiime V, Paparini S, Nakyambadde H, et al. ‘Because we all have to grow up’: supporting adolescents in Uganda to develop core competencies to transition towards managing their HIV more independently. J Int AIDS Soc. 2020. 10.1002/jia2.25552.
    1. Pantelic M, Casale M, Cluver L, Toska E, Moshabela M. Multiple forms of discrimination and internalized stigma compromise retention in HIV care among adolescents: findings from a south African cohort. J Int AIDS Soc. 2020. 10.1002/jia2.25488.
    1. Gitahi N, Camlin C, Mwania V, Ngure K, Auerswald C, Bukusi E. Psychosocial needs among older perinatally infected adolescents living with HIV and transitioning to adult care in Kenya. PLoS One. 2020. 10.1371/journal.pone.0233451.
    1. Bongfen MC, Torpey K, Ganle J, Ankomah A. Level of adherence and associated factors among HIV-positive adolescents on antiretroviral therapy in Cameroon. Afr J of AIDS Res. 2020. 10.2989/16085906.2020.1833055.
    1. Dahourou DL, Gautier-Lafaye C, Teasdale CA, Renner L, Yotebieng M, Desmonde S, et al. Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes. J Int AIDS Soc. 2017. 10.7448/IAS.20.4.21528.
    1. Hickson W, Mayers PM. Understanding how young people become motivated to take their human immunodeficiency virus medication (antiretroviral therapy) and how the need for adherence is communicated. Health SA. 2020. 10.4102/hsag.v25i0.1458.
    1. Roberts ST, Edwards P, Mulenga D, Chelwa N, Nyblade L, Brander C, et al. Family support for adolescent girls and young women living with HIV in Zambia: benefits, challenges, and recommendations for intervention development. J Assoc Nurses AIDS Care. 2021. 10.1097/JNC.0000000000000225.
    1. Rencken CA, Harrison AD, Mtukushe B, Bergam S, Pather A, Sher R, et al. ‘Those people motivate and inspire me to take my treatment.’ Peer support for adolescents living with HIV in Cape Town, South Africa. Int Assoc Provid AIDS Care. 2021. 10.1177/23259582211000525.
    1. Crowley T, van der Merwe A, Kidd M, Skinner D. Adolescent human immunodeficiency virus self-management: associations with treatment adherence, viral suppression, sexual risk behaviours and health-related quality of life. S Afr J HIV Med. 2020. 10.4102/sajhivmed.v21i1.1054.
    1. Madiba S, Josiah U. Perceived stigma and fear of unintended disclosure are barriers in medication adherence in adolescents with perinatal HIV in Botswana: a qualitative study. Biomed Res Int. 2019. 10.1155/2019/9623159.
    1. Nasuuna E, Kigozi J, Muwanguzi PA, Babirye J, Kiwala L, Muganzi A, et al. Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counseling program in Uganda: a qualitative study. BMC Health Serv Res. 2019. 10.1186/s12913-019-3963-y.
    1. van Wyk BE, Davids LC. Challenges to HIV treatment adherence amongst adolescents in a low socio-economic setting in Cape Town. South Afr J HIV Med. 2019. 10.4102/sajhivmed.v20i1.1002.
    1. Burns R, Magalasi D, Blasco P, Szumilin E, Pasquier E, Schramm B, et al. ‘We give them threatening advice … ’: expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi. J Int AIDS Soc. 2020. 10.1002/jia2.25459.
    1. Denison JA, Burke VM, Miti S, Nonyane BAS, Frimpong C, Merrill KG, et al. Project YES! Youth engaging for success: a randomized controlled trial assessing the impact of a clinic-based peer mentoring program on viral suppression, adherence and internalized stigma among HIV-positive youth (15-24 years) in Ndola. Zambia PLoS One. 2020. 10.1371/journal.pone.0230703.
    1. Mavhu W, Willis N, Mufuka J, Bernays S, Tshuma M, Mangenah C, et al. Effect of a differentiated service delivery model on virological failure in adolescents with HIV in Zimbabwe (Zvandiri): a cluster-randomised controlled trial. Lancet Glob Health. 2020. 10.1016/S2214-109X(19)30526-1.
    1. African Network for the Care of Children Affected by HIV/AIDS (ANECCA): Pocket Guide on Counseling and Psychosocial Care for Children and Adolescents Living with and Affected by HIV in Africa. (2018). Accessed 13 July 2021.
    1. Calabrese SK, Mayer KH. Providers should discuss U=U with all patients living with HIV. Lancet HIV. 2019. 10.1016/S2352-3018(19)30030-X.
    1. Miti S, Handema R, Mulenga L, Mwansa JK, Abrams E, Frimpong C, et al. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola. Zambia. PLoS One. 2020. 10.1371/journal.pone.0236156.
    1. Dow DE, Shayo AM, Cunningham CK, Mmbaga B. HIV-1 drug resistance and virologic outcomes among Tanzanian youth living with HIV. Pediatr Infect Dis J. 2019. 10.1097/INF.0000000000002288.
    1. Muri L, Gamell A, Ntamatungiro AJ, Glass TR, Luwanda LB, Battegay M, et al. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern. AIDS. 2017. 10.1097/QAD.0000000000001273.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit